BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15598662)

  • 1. The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.
    Hodgson MC; Astapova I; Cheng S; Lee LJ; Verhoeven MC; Choi E; Balk SP; Hollenberg AN
    J Biol Chem; 2005 Feb; 280(8):6511-9. PubMed ID: 15598662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.
    Hodgson MC; Shen HC; Hollenberg AN; Balk SP
    Mol Cancer Ther; 2008 Oct; 7(10):3187-94. PubMed ID: 18852122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC; Astapova I; Hollenberg AN; Balk SP
    Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
    Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP
    Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
    Berrevoets CA; Umar A; Trapman J; Brinkmann AO
    Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-androgen effects of the pyrethroid pesticide cypermethrin on interactions of androgen receptor with corepressors.
    Pan C; Wang Q; Liu YP; Xu LF; Li YF; Hu JX; Jiang M; Zhang JP; Zhang MR; Yu HM; Zhou JL; Zhou XL; Xu LC
    Toxicology; 2013 Sep; 311(3):178-83. PubMed ID: 23831764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.
    Schulz M; Eggert M; Baniahmad A; Dostert A; Heinzel T; Renkawitz R
    J Biol Chem; 2002 Jul; 277(29):26238-43. PubMed ID: 12011091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.
    Wagner BL; Norris JD; Knotts TA; Weigel NL; McDonnell DP
    Mol Cell Biol; 1998 Mar; 18(3):1369-78. PubMed ID: 9488452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor.
    Song LN; Coghlan M; Gelmann EP
    Mol Endocrinol; 2004 Jan; 18(1):70-85. PubMed ID: 14593076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repressors of androgen and progesterone receptor action.
    Agoulnik IU; Krause WC; Bingman WE; Rahman HT; Amrikachi M; Ayala GE; Weigel NL
    J Biol Chem; 2003 Aug; 278(33):31136-48. PubMed ID: 12771131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
    Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
    Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Androgen receptor and SMRT].
    Liao GQ; Tang HH; Lü XS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):157-62. PubMed ID: 16145900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
    Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
    Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.
    Dotzlaw H; Papaioannou M; Moehren U; Claessens F; Baniahmad A
    Mol Cell Endocrinol; 2003 Dec; 213(1):79-85. PubMed ID: 15062576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.